Literature DB >> 10504044

P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties.

M Port1, D Meyer, B Bonnemain, C Corot, M Schaefer, O Rousseaux, C Simonot, P Bourrinet, S Benderbous, A Dencausse, L Devoldere.   

Abstract

RATIONALE AND
OBJECTIVES: In this paper we discuss novel MR imaging blood pool agents characterized by new pharmacokinetic properties.
METHODS: The pharmacokinetics of the products were studied in a rabbit model. The potential of these new products was demonstrated in experimental MR imaging. RESULTS AND
CONCLUSION: Three main classes of blood pool agents have been defined and characterized according to their pharmacokinetic properties: low diffusion agents, rapid clearance blood pool agents, slow clearance blood pool agents. Each kind of blood pool agent is expected to have different diagnostic applications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504044     DOI: 10.1007/BF02594595

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  4 in total

1.  Rationale and applications for macromolecular Gd-based contrast agents.

Authors:  R C Brasch
Journal:  Magn Reson Med       Date:  1991-12       Impact factor: 4.668

Review 2.  [Vascular contrast agents. Definition and potential applications].

Authors:  B Bonnemain
Journal:  Ann Pharm Fr       Date:  1998

3.  MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging.

Authors:  R B Lauffer; D J Parmelee; H S Ouellet; R P Dolan; H Sajiki; D M Scott; P J Bernard; E M Buchanan; K Y Ong; Z Tyeklár; K S Midelfort; T J McMurry; R C Walovitch
Journal:  Acad Radiol       Date:  1996-08       Impact factor: 3.173

4.  Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.

Authors:  C Corot; M Schaefer; S Beauté; P Bourrinet; S Zehaf; V Bénizé; M Sabatou; D Meyer
Journal:  Acta Radiol Suppl       Date:  1997
  4 in total
  4 in total

Review 1.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

2.  Standardized MR protocol for the evaluation of MRA sequences and/or contrast agents effects in high-degree arterial stenosis analysis.

Authors:  Bruno Marchand; Philippe C Douek; Philippe Robert; Claire Corot; Jean Pierre Roux; Patrice Adeleine; Marcela Hernandez-Hoyos; Yannick Cremillieux; Maciej Orkisz; Emmanuelle Canet
Journal:  MAGMA       Date:  2002-06       Impact factor: 2.533

3.  P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.

Authors:  M Port; C Corot; O Rousseaux; I Raynal; L Devoldere; J M Idée; A Dencausse; S Le Greneur; C Simonot; D Meyer
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

4.  Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model.

Authors:  F Bourasset; A Dencausse; P Bourrinet; M Ducret; C Corot
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.